Ropinirole
Antiparkinsonian (dopamine agonist)
Brand names: Requip
Oral health effects
Xerostomia (dry mouth)
Reduced salivary flow with elevated caries and discomfort risk.
Clinical management: Hydration, salivary substitutes, high-fluoride caries prevention.
Dizziness on standing (orthostatic hypotension)
Hypotension, including orthostatic hypotension, and syncope are label warnings, especially during dose escalation; Parkinson's itself impairs blood-pressure regulation.
Clinical management: Raise the chair slowly at the end of the appointment and have the patient sit upright for a minute or two before standing; steady them as they get up. Ask about dizziness on standing, especially after dose changes or in older patients.
Involuntary movements (dyskinesia)
Dopamine agonists can cause or worsen dyskinesia, including orofacial movements, especially with levodopa (label: 34% vs 13% on placebo when added to levodopa).
Clinical management: Expect involuntary jaw, tongue or limb movements that can interrupt instrumentation; use short appointments, bite blocks and good head support, and schedule care when medication is working well (patient-reported 'on' time).
Sources
- A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Wolff A, Joshi RK, Ekström J, et al. Drugs in R&D, 2017.
- Ropinirole prescribing information (FDA label) SOLCO HEALTHCARE US, LLC / DailyMed, 2025.